Cardiac output improvement by pecavaptan: A novel dualâacting vasopressin V1a/ V2 receptor antagonist in experimental heart failure
Mondritzki, Thomas, Mai, Thuy Anh, Vogel, Julia, Pook, Elisabeth, Wasnaire, Pierre, Schmeck, Carsten, Hüser, Jörg, Dinh, Wilfried, Truebel, Hubert, Kolkhof, PeterJournal:
European Journal of Heart Failure
DOI:
10.1002/ejhf.2001
Date:
September, 2020
File:
PDF, 2.31 MB
2020